Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for Q9RNV1
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-Q9RNV1-F1 | Predicted | AlphaFoldDB |
No variants for Q9RNV1
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| No variants for Q9RNV1 | |||||
No associated diseases with Q9RNV1
9 regional properties for Q9RNV1
| Type | Name | Position | InterPro Accession |
|---|---|---|---|
| domain | Elongation factor EFG, domain V-like | 599 - 686 | IPR000640 |
| domain | Translational (tr)-type GTP-binding domain | 8 - 282 | IPR000795 |
| domain | Translation elongation factor EFTu-like, domain 2 | 323 - 390 | IPR004161 |
| domain | Small GTP-binding protein domain | 9 - 180 | IPR005225 |
| domain | Translation elongation factor EFG/EF2, domain IV | 478 - 597 | IPR005517 |
| domain | Elongation factor G, domain III | 404 - 479 | IPR009022 |
| conserved_site | Tr-type G domain, conserved site | 51 - 66 | IPR031157 |
| domain | EFG, domain V | 602 - 679 | IPR035649 |
| domain | Elongation Factor G, domain II | 403 - 476 | IPR041095 |
2 GO annotations of cellular component
| Name | Definition |
|---|---|
| integral component of membrane | The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. |
| plasma membrane | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
2 GO annotations of molecular function
| Name | Definition |
|---|---|
| ATP binding | Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator. |
| DNA binding | Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid). |
4 GO annotations of biological process
| Name | Definition |
|---|---|
| cell cycle | The progression of biochemical and morphological phases and events that occur in a cell during successive cell replication or nuclear replication events. Canonically, the cell cycle comprises the replication and segregation of genetic material followed by the division of the cell, but in endocycles or syncytial cells nuclear replication or nuclear division may not be followed by cell division. |
| cell division | The process resulting in division and partitioning of components of a cell to form more cells; may or may not be accompanied by the physical separation of a cell into distinct, individually membrane-bounded daughter cells. |
| chromosome segregation | The process in which genetic material, in the form of chromosomes, is organized into specific structures and then physically separated and apportioned to two or more sets. In eukaryotes, chromosome segregation begins with the condensation of chromosomes, includes chromosome separation, and ends when chromosomes have completed movement to the spindle poles. |
| sporulation resulting in formation of a cellular spore | The process in which a relatively unspecialized cell acquires the specialized features of a cellular spore, a cell form that can be used for dissemination, for survival of adverse conditions because of its heat and dessication resistance, and/or for reproduction. |
No homologous proteins in AiPD
| UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
|---|---|---|---|---|
| No homologous proteins | ||||
| 10 | 20 | 30 | 40 | 50 | 60 |
| MAKKRAKKRA | PAKKRQQKKQ | QSQMQPLWFE | ILGVVLIGIA | IIMIFEFGII | GRGLSAFSRF |
| 70 | 80 | 90 | 100 | 110 | 120 |
| LLGNWYVALP | FLIIVQALIF | MIKRQIGGYK | HRIVIGCLFI | LGSMLLFSHV | HLFQTLYESK |
| 130 | 140 | 150 | 160 | 170 | 180 |
| VLMSNSALKE | TWKVLITNDG | IHDQTGTLGG | GMLGAVLFAM | FYSLVDSSGA | TVAGVLLLLI |
| 190 | 200 | 210 | 220 | 230 | 240 |
| GIILLTGKAL | IPFLVEQTPI | LMNDIKKKWA | AREKKSVKSP | EEKRKESARS | NRKSKPKPVD |
| 250 | 260 | 270 | 280 | 290 | 300 |
| TSEMEAVQEN | PEPASEPIIS | SFTAKIEQAT | QPEIVQEKQS | KAQEDSTLDP | KDPVTDYPVM |
| 310 | 320 | 330 | 340 | 350 | 360 |
| GGEQENESYV | LPSAKLLEPP | VASDQSGEYD | LIQANAKKLE | KTFLSFGVKT | RVTQVHLGPA |
| 370 | 380 | 390 | 400 | 410 | 420 |
| VTKYEILPDT | GVKVSRIVSL | ADDIALALAA | SGIRIEAPIP | GKSAVGIEVP | NNAVAMVSLR |
| 430 | 440 | 450 | 460 | 470 | 480 |
| EVLESKENNP | PEAKLLVGLG | RDVTGQAMMT | ELNKMPHVLI | AGATGSGKSV | CVNGIIMSII |
| 490 | 500 | 510 | 520 | 530 | 540 |
| MRAKPHEVKM | MMIDPKMVEL | NVFNGIPHLL | APVVTDPRKA | AQALQRVVSE | MERRYELFSH |
| 550 | 560 | 570 | 580 | 590 | 600 |
| TGTRNIEGYN | NHIEQWNEDH | DEKHPRMPYI | VVIVDELADL | MMVASSDVED | SITRLAQMAR |
| 610 | 620 | 630 | 640 | 650 | 660 |
| AAGIHLIIAT | QRPSVDVITG | IIKANIPSRI | AFAVSSAIDS | RTILDGAGAE | KLLGRGDMLF |
| 670 | 680 | 690 | 700 | 710 | 720 |
| LPAGASKPTR | IQGAFVSDEE | VEAVVNFVIE | QQKAQYQEEM | IPTEVEVVAP | HEETDELYDE |
| 730 | 740 | 750 | 760 | 770 | |
| AVQMVVDMQT | ASVSMIQRRF | RVGYARAARI | VDQMEARGVV | GPPEGSKPRH | VLLTKSKLEM |